364 related articles for article (PubMed ID: 22251008)
1. Alternative medicines as emerging therapies for inflammatory bowel diseases.
Singh UP; Singh NP; Busbee B; Guan H; Singh B; Price RL; Taub DD; Mishra MK; Nagarkatti M; Nagarkatti PS
Int Rev Immunol; 2012 Feb; 31(1):66-84. PubMed ID: 22251008
[TBL] [Abstract][Full Text] [Related]
2. Complementary Therapies in Inflammatory Bowel Diseases.
Yanai H; Salomon N; Lahat A
Curr Gastroenterol Rep; 2016 Dec; 18(12):62. PubMed ID: 27747459
[TBL] [Abstract][Full Text] [Related]
3. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].
Lakatos L; Czeglédi Z; Dávid G; Kispál Z; Kiss LS; Palatka K; Kristóf T; Molnár T; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovács A; Rácz I; Lakatos PL
Orv Hetil; 2010 Feb; 151(7):250-8. PubMed ID: 20133244
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and inflammatory bowel disease.
Shi Y; Zhou J; Jiang B; Miao M
Ann N Y Acad Sci; 2017 Sep; 1403(1):38-47. PubMed ID: 28945937
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use amongst patients with inflammatory bowel disease.
Lal S; Prasad N; Ryan M; Tangri S; Silverberg MS; Gordon A; Steinhart H
Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):891-6. PubMed ID: 21795981
[TBL] [Abstract][Full Text] [Related]
6. Complementary and Integrative Gastroenterology.
Korzenik J; Koch AK; Langhorst J
Med Clin North Am; 2017 Sep; 101(5):943-954. PubMed ID: 28802472
[TBL] [Abstract][Full Text] [Related]
7. Review article: complementary and alternative therapies for inflammatory bowel disease.
Langmead L; Rampton DS
Aliment Pharmacol Ther; 2006 Feb; 23(3):341-9. PubMed ID: 16422993
[TBL] [Abstract][Full Text] [Related]
8. Application of Herbaceous Medications for Inflammatory Bowel Disease as a Complementary and Alternative Therapy.
Lin Z; Wu H; Fu Y; Dai S
Inflamm Bowel Dis; 2019 Nov; 25(12):1886-1895. PubMed ID: 31504527
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases.
Langhorst J; Wulfert H; Lauche R; Klose P; Cramer H; Dobos GJ; Korzenik J
J Crohns Colitis; 2015 Jan; 9(1):86-106. PubMed ID: 25518050
[TBL] [Abstract][Full Text] [Related]
10. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.
Coelho MR; Romi MD; Ferreira DMTP; Zaltman C; Soares-Mota M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751776
[TBL] [Abstract][Full Text] [Related]
11. Incidence, and natural history of inflammatory bowel disease in Castilla y León: Prospective and multicenter epidemiological study.
Sáiz-Chumillas RM; Barrio J; Fernández-Salazar L; Arias L; Sierra Ausín M; Piñero C; Fuentes Coronel A; Mata L; Vásquez M; Carbajo A; Alcaide N; Cano N; Nuñez A; Fradejas P; Ibáñez M; Hernández L; Sicilia B
Gastroenterol Hepatol; 2023 Feb; 46(2):102-108. PubMed ID: 35569540
[TBL] [Abstract][Full Text] [Related]
12. International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey.
Rubin DT; Sninsky C; Siegmund B; Sans M; Hart A; Bressler B; Bouhnik Y; Armuzzi A; Afzali A
Inflamm Bowel Dis; 2021 Nov; 27(12):1942-1953. PubMed ID: 33512475
[TBL] [Abstract][Full Text] [Related]
13. Topical delivery of steroids in inflammatory bowel disease.
Girlich C; Scholmerich J
Curr Drug Deliv; 2012 Jul; 9(4):345-9. PubMed ID: 22762277
[TBL] [Abstract][Full Text] [Related]
14. Predictors of corticosteroid-dependent and corticosteroid-refractory inflammatory bowel disease: analysis of a Chinese cohort study.
Chow DK; Sung JJ; Tsoi KK; Wong VW; Wu JC; Leong RW; Chan FK
Aliment Pharmacol Ther; 2009 Apr; 29(8):843-54. PubMed ID: 19154567
[TBL] [Abstract][Full Text] [Related]
15. Complementary therapies in inflammatory bowel diseases.
Esters P; Dignass A
Curr Drug Targets; 2014; 15(11):1079-88. PubMed ID: 25182607
[TBL] [Abstract][Full Text] [Related]
16. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
17. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
18. European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease.
Torres J; Ellul P; Langhorst J; Mikocka-Walus A; Barreiro-de Acosta M; Basnayake C; Ding NJS; Gilardi D; Katsanos K; Moser G; Opheim R; Palmela C; Pellino G; Van der Marel S; Vavricka SR
J Crohns Colitis; 2019 May; 13(6):673-685e. PubMed ID: 30820529
[TBL] [Abstract][Full Text] [Related]
19. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
Iborra M; Beltrán B; Maroto N; Navarro-Cortés P; Boscá-Watts M; Ferrer-Bradley I; García-Morales N; Sáez-González E; Hinojosa J; Mínguez M; Nos P
Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573
[TBL] [Abstract][Full Text] [Related]
20. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
